Vanguard Group’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17.6M Buy
1,475,120
+191,142
+15% +$2.28M ﹤0.01% 2612
2025
Q1
$15.3M Buy
1,283,978
+35,585
+3% +$423K ﹤0.01% 2626
2024
Q4
$19.2M Buy
1,248,393
+5,400
+0.4% +$83.1K ﹤0.01% 2605
2024
Q3
$13.9M Buy
1,242,993
+26,627
+2% +$298K ﹤0.01% 2788
2024
Q2
$6.56M Sell
1,216,366
-91,333
-7% -$492K ﹤0.01% 3127
2024
Q1
$8.89M Sell
1,307,699
-995
-0.1% -$6.77K ﹤0.01% 3026
2023
Q4
$8.89M Buy
1,308,694
+33,414
+3% +$227K ﹤0.01% 3015
2023
Q3
$6.39M Buy
1,275,280
+55,784
+5% +$279K ﹤0.01% 3145
2023
Q2
$8.83M Buy
1,219,496
+125,667
+11% +$910K ﹤0.01% 3017
2023
Q1
$9.23M Buy
1,093,829
+72,487
+7% +$612K ﹤0.01% 2979
2022
Q4
$8.65M Buy
1,021,342
+33,474
+3% +$284K ﹤0.01% 3018
2022
Q3
$10.2M Buy
987,868
+7,806
+0.8% +$80.9K ﹤0.01% 2943
2022
Q2
$12.8M Sell
980,062
-100,594
-9% -$1.31M ﹤0.01% 2852
2022
Q1
$11.2M Buy
1,080,656
+154,867
+17% +$1.61M ﹤0.01% 3086
2021
Q4
$10.4M Buy
925,789
+64,316
+7% +$722K ﹤0.01% 3179
2021
Q3
$15.3M Buy
861,473
+38,439
+5% +$682K ﹤0.01% 3001
2021
Q2
$15.7M Buy
823,034
+166,851
+25% +$3.19M ﹤0.01% 2963
2021
Q1
$13.9M Buy
656,183
+61,107
+10% +$1.29M ﹤0.01% 2976
2020
Q4
$9.46M Buy
595,076
+139,918
+31% +$2.22M ﹤0.01% 3024
2020
Q3
$2.49M Hold
455,158
﹤0.01% 3427
2020
Q2
$1.62M Hold
455,158
﹤0.01% 3492
2020
Q1
$1.63M Buy
455,158
+123,141
+37% +$441K ﹤0.01% 3353
2019
Q4
$1.59M Buy
332,017
+87,674
+36% +$421K ﹤0.01% 3511
2019
Q3
$1.24M Buy
+244,343
New +$1.24M ﹤0.01% 3590